文献速递关节外科骨质疏松与代谢性骨病

股骨头坏死患者的流行病学、管理及手术趋势的系统综述

Epidemiology, Management, and Systematic Review of Surgical Trends for Patients Who Have Osteonecrosis of the Femoral Head.
PubMed 文献 · J Arthroplasty · 2025-06-07

基于美国国家数据库(2015至2024年)分析61,903例股骨头坏死患者,特发性占78.1%,皮质类固醇使用是最常见危险因素(75%),全髋关节置换术在1年和5年内分别为22.6%和25.2%。系统综述纳入5篇文献,确认全髋关节置换术增加而保髋手术总体下降,但年轻患者中保髋手术更常见,亚洲数据库保髋手术使用多于美国。

要点

  • 股骨头坏死占美国骨坏死负担的40%,皮质类固醇使用是最常见危险因素(75%)。
  • 全髋关节置换术是主要治疗方式,1年内占22.6%,5年内占25.2%。
  • 系统综述显示全髋关节置换术增加而保髋手术总体下降,但年轻患者中保髋手术更常见。

核心结论

  • 股骨头坏死占美国骨坏死负担的40%,皮质类固醇使用是最常见危险因素。
  • 手术干预尤其是全髋关节置换术是主要治疗方式,其他手术和非手术治疗使用有限。
  • 系统综述确认全髋关节置换术发生率较保髋手术增加,但保髋手术在年轻患者中更常见,且存在地理差异,韩国和日本患者更可能接受保髋手术。
  • 这些发现强调需要共识驱动的治疗指南。

研究设计与样本

  • 使用研究网络2015至2024年数据,通过ICD-10-CM代码识别股骨头坏死患者,排除其他部位骨坏死。
  • 描述基线人口学、合并症和地理分布,评估诊断后1年和5年内治疗趋势。
  • 按PRISMA指南系统检索三个数据库,最终纳入5篇文献,纳入标准为提供至少10年手术趋势数据。
  • 证据等级III。

主要发现

  • 61,903例髋骨坏死患者中,特发性病因占78.1%(n=48,365),其中男性占52.1%(n=25,197),诊断年龄范围为40至72岁。
  • 美国南部患病率最高(42%),东北部次之(30%)。
  • 皮质类固醇使用是最常见危险因素(75%,n=36,274),其次为血脂异常(49%,n=23,699)和尼古丁使用(27%,n=13,058)。
  • 全髋关节置换术在1年内占22.6%(n=10,931),5年内占25.2%(n=12,187)。
  • 系统综述中,全髋关节置换术是最常见手术,保髋手术在研究时间段内总体下降,但在年轻患者中更常见且发生率似有增加;亚洲国家数据库研究使用保髋手术多于美国数据库研究。

关键数值与推荐

  • 系统综述纳入标准:提供股骨头坏死患者至少10年手术趋势数据的文章。
  • 共纳入5篇文章。
  • 证据等级III。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Osteonecrosis is a debilitating condition characterized by bone tissue death and disrupted vascular circulation, most commonly affecting the femoral head. This study aimed to assess the epidemiology and surgical trends of hip osteonecrosis in the United States using a comprehensive national database, as well as to review the current literature on historical and contemporary surgical trends for patients who have osteonecrosis of the femoral head (ONFH). METHODS: Data from a research network (2015 to 2024) were used to identify patients diagnosed with ONFH using International Classification of Diseases, 10th revision, Clinical Modification codes. Patients who had osteonecrosis at other sites were excluded. Baseline demographics, comorbidities, and geographic distribution were characterized. Treatment trends were evaluated within 1 and 5 years of diagnosis. Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we conducted a systematic review across three databases, resulting in a total of five articles. Articles met the inclusion criteria if they provided data regarding surgical trends of patients who have ONFH over at least a 10-year period. RESULTS: From the recent database, of 61,903 patients who have hip osteonecrosis, the majority were of idiopathic etiology (78.1%, n = 48,365). Men comprised 52.1% (n = 25,197) of the idiopathic cases, and the age at diagnosis ranged between 40 and 72 years. The Southern United States had the highest prevalence of hip osteonecrosis (42%), followed by the Northeast (30%). Corticosteroid use was the most common risk factor (75%, n = 36,274), followed by dyslipidemias (49%, n = 23,699) and nicotine use (27%, n = 13,058). Total hip arthroplasty (THA) was the predominant treatment modality within 1 year (22.6%, n = 10,931) and 5 years (25.2%, n = 12,187). In our systematic review, we found that THA was the most common procedure performed for patients who have ONFH, and joint-preserving procedures generally declined over the studies' time periods. However, joint-preserving procedures were more commonly performed in younger patients and appeared to increase in incidence over the studies' time periods. Studies using a database from Asian countries used more joint-preserving procedures than studies using a database based in the United States. CONCLUSIONS: Hip osteonecrosis accounts for 40% of the osteonecrosis burden in the United States, and corticosteroid use was identified as the most common risk factor. Surgical interventions, particularly THA, are the primary modality of treatment, with limited use of other surgical and nonsurgical management. Our systematic review confirmed that the incidence of THA has increased over the years compared to joint-preserving procedures, although the latter has become more common in younger patients. There also appears to be considerable geographic variation in surgical trends, as patients in South Korea and Japan are more likely to undergo joint-preserving procedures. These findings underscore the need for consensus-driven treatment guidelines. LEVEL OF EVIDENCE: III.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Buddhiraju A, Khanuja HS, Hegde V, et al. Epidemiology, Management, and Systematic Review of Surgical Trends for Patients Who Have Osteonecrosis of the Femoral Head. J Arthroplasty. 2025. PMID: 40490143. doi:10.1016/j.arth.2025.06.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。